Anita Dushyanth
Stock Analyst at Berenberg
(2.73)
# 2,106
Out of 5,056 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $23.55 | -15.07% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $3.12 | +316.67% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.84 | +65,117.39% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $24.39 | +281.30% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $23.55
Upside: -15.07%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $3.12
Upside: +316.67%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.84
Upside: +65,117.39%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $24.39
Upside: +281.30%